India's Hetero prices experimental COVID-19 drug remdesivir at $71 per 100 mg vial - Reuters

4:25am PDT - June 24th, 2020    remdesivir - Reuters

India's Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at 5,400 rupees ($71) per 100-milligram vial, the drugmaker said on Wednesday, as it prepares to ship them to hospitals in the country.